{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-011110","form_type":"8-K","ticker":"IBAC","cik":"0001998781","company_name":"IB Acquisition Corp.","filed_at":"2026-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.960044+00:00","generated_at":"2026-05-15T09:58:24.722416+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"GNQ Insilico enters collaboration with Fortune 100 tech firm for AI-driven drug discovery","bullets":["GNQ Insilico signed a Joint Initiative Agreement with a Fortune 100 global technology company.","Collaboration combines GNQ's AI platforms with partner's consulting, cloud, and quantum computing.","Initial term of two years, global territory, non-exclusive, with option to extend.","Partnership aims to advance AI-driven drug discovery and precision medicine solutions.","Relates to proposed business combination between IB Acquisition Corp. (IBAC) and GNQ."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-011110","json":"https://secwatch.observer/filing/0001493152-26-011110.json","markdown":"https://secwatch.observer/filing/0001493152-26-011110.md","text":"https://secwatch.observer/filing/0001493152-26-011110.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1998781/000149315226011110/0001493152-26-011110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1998781/000149315226011110/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:58:24.722416+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}